Risk Assessment
Year after year, beginning in 1998, Churchill & Harriman has conducted over seven hundred risk assessments for global leaders including Fortune 50 corporations in the life sciences and financial services industries, business process outsourcing service providers, and a central bank. C&H is privileged to contribute to The Financial Services Roundtable and to PhRMA in the establishment and implementation of industry-wide risk assessment and management programs. Additionally, C&H earned the distinction of being the first approved ISO 27001 and BS 25999 Associate Consultancy by a leading global Registrar.
Churchill & Harriman’s risk assessment methodologies are employed at the appropriate level of granularity to help you manage both internal risk, and risk within your global supply chain/vendor base. Our validated and comprehensive approach, employing industry best practices, ensures our methodologies and techniques are consistently evolving to anticipate and comply with the continuously evolving landscape of global regulations and laws.
We can help you satisfy all of your internal and external risk assessment requirements. We work with customers to establish risk assessment criteria. We can schedule, conduct, and report on risk assessments within your internal operations, and, around the world for you. We work with you to establish reporting templates that are guidelined to address those specific legal, regulatory, and contractual requirements that are important to you. C&H's solutions will also help you manage enforcement of your enterprise security policies in a consistent, repeatable, and efficient manner.
The most discerning organizations depend on C&H to satisfy their risk assessment requirements.
To learn more about Churchill & Harriman, please click here.
Cost Optimization for the Global Life Sciences Community
"Thank you for Churchill & Harriman’s notable contributions to both the SAFE Bio-Pharma Association and its member companies. C&H’s validated business process development expertise, coupled with your institutional identity and authentication management competencies, has all been successfully applied for the good of the entire SAFE community. Churchill & Harriman has exceeded my very high expectations in propelling this challenging initiative forward. Please accept my gratitude on behalf of the SAFE Bio-Pharma Association."
Gary W. Secrest, Chairman,
SAFE Bio-Pharma Association
Mollie Shields-Uehling, President and CEO,
SAFE Bio-Pharma Association